Prescribing of NICE-recommended tablets for endometriosis and fibroids has more than tripled in a year across England, giving thousands of additional women another option to manage painful and debilitating symptoms.
Innovative AI technologies have the potential to act like a ‘second pair of eyes’, helping radiologists review prostate MRI scans.
Around 1,000 people with HER2-low advanced breast cancer can now be offered Enhertu after NICE recommended it for routine NHS use.
People with obsessive-compulsive disorder (OCD) and body dysmorphic disorder (BDD) could be identified earlier and offered more appropriate treatment under draft NICE guidance published today.
Four technology appraisals for type 2 diabetes have been updated, and guidance on 4 further medicines is being withdrawn, as part of NICE's first test of a new way of keeping all its guidance aligned.
Hundreds of thousands of people with type 2 diabetes could swap daily insulin injections for a once-a-week jab, following a NICE recommendation today (Thursday, 20 August). The switch could cut the number of injections each patient needs by 85%.
Page 1 of 51